Cosmo Fowler, M.D., from Emory University in Atlanta, and colleagues examined data from the TriNetX U.S. Collaborative Network to examine whether OSA modifies outcomes in patients with T2DM receiving ...
Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have ...
When the core set of symptoms are the same, how can you tell diabetes type 1.5, or LADA, apart from it's famous cousins?
Why are women more prone to Alzheimer's and multiple sclerosis? A UCLA study reveals an X-linked gene causing brain inflammation and how metformin might help.
Talking With Docs on MSN
Could metformin extend your lifespan?
What happened after Michael J. Fox finally met Eric Stoltz 40 years after replacing the actor in 'Back to the Future' Bruce ...
Dr Sudhir Kumar from Apollo Hospitals warns that long-term use of metformin and acidity medicines (PPIs) may reduce Vitamin ...
A new large study suggests that a group of diabetes medications called GLP-1 receptor agonists may be better than metformin ...
Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...
Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...
New Delhi, October 16 (IANS): US researchers have identified a gene on the X chromosome that drives inflammation in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback